Family history of Alzheimer's disease alters cognition and is modified by medical and genetic factors
Author
Talboom, Joshua SHåberg, Asta
De Both, Matthew D
Naymik, Marcus A
Schrauwen, Isabelle
Lewis, Candace R
Bertinelli, Stacy F
Hammersland, Callie
Fritz, Mason A
Myers, Amanda J
Hay, Meredith
Barnes, Carol A
Glisky, Elizabeth
Ryan, Lee
Huentelman, Matthew J
Affiliation
Univ ArizonaIssue Date
2019-06-18
Metadata
Show full item recordPublisher
ELIFECitation
Talboom, J. S., Håberg, A., De Both, M. D., Naymik, M. A., Schrauwen, I., Lewis, C. R., ... & Hay, M. (2019). Family history of Alzheimer’s disease alters cognition and is modified by medical and genetic factors. eLife, 8, e46179.Journal
ELIFERights
Copyright Talboom et al. This article is distributed under the terms of the Creative Commons Attribution License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
In humans, a first-degree family history of dementia (FH) is a well-documented risk factor for Alzheimer's disease (AD); however, the influence of FH on cognition across the lifespan is poorly understood. To address this issue, we developed an internet-based paired-associates learning (PAL) task and tested 59,571 participants between the ages of 18-85. FH was associated with lower PAL performance in both sexes under 65 years old. Modifiers of this effect of FH on PAL performance included age, sex, education, and diabetes. The Apolipoprotein E epsilon 4 allele was also associated with lower PAL scores in FH positive individuals. Here we show, FH is associated with reduced PAL performance four decades before the typical onset of AD; additionally, several heritable and non-heritable modifiers of this effect were identified.Note
Open access journalISSN
2050-084XPubMed ID
31210642Version
Final published versionSponsors
Mueller Family Charitable Trust; Arizona Department of Health Services; National Institutes of Health [R01-AG041232, R01-AG049465-05]; Flinn Foundationae974a485f413a2113503eed53cd6c53
10.7554/eLife.46179
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright Talboom et al. This article is distributed under the terms of the Creative Commons Attribution License.
Related articles
- The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.
- Authors: Xu G, McLaren DG, Ries ML, Fitzgerald ME, Bendlin BB, Rowley HA, Sager MA, Atwood C, Asthana S, Johnson SC
- Issue date: 2009 Feb
- The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.
- Authors: Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA
- Issue date: 2006 May 31
- Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
- Authors: McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP
- Issue date: 2010 Oct 8
- fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease.
- Authors: Trivedi MA, Schmitz TW, Ries ML, Hess TM, Fitzgerald ME, Atwood CS, Rowley HA, Asthana S, Sager MA, Johnson SC
- Issue date: 2008
- Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
- Authors: Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D, AIBL Research Group
- Issue date: 2013 Jul

